Trial
NCT05129423
A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Genentech, Inc.
Collaborators
—
Condition
Chronic Spontaneous Urticaria
Intervention
MTPS9579A
Why stopped
Development of MTPS9579A was terminated for strategic/business reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-18